Resultados da busca - Pascal Do

Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC por Paul Lesueur, Alexandre Escande, Juliette Thariat, Enora Vauléon, Isabelle Monnet, Alexis Cortot, Delphine Lerouge, Serge Danhier, Pascal Dô, Catherine Dubos‐Arvis, Christos Chouaïd, Radj Gervais

Obter o texto integral

Management and outcomes of non–small cell lung cancer patients with rapid progression under second‐or‐more‐line immune checkpoint inhibitors: ERORECI study (GFPC 2016‐04) por Alain Vergnenegre, Margaux Geier, Florian Guisier, Regine Lamy, Bénédicte Comet, Gwenaelle Le Garff, Pascal Do, Henri Janicot, Hugues Morel, Chantal Decroisette, Michel Andre, Lionel Falchero, Nicolas Paleiron, Isabelle Monnet, the GFPC Team

Obter o texto integral

Impact of KRAS G12C mutation on the efficacy of chemoradiotherapy in patients with unresectable stage II or III non-small cell lung cancer por Jean Cabon, Delphine Lerouge, Sebastien Thureau, Jacques Balosso, Marin Guigo, Radj Gervais, Catherine Dubos, Pascal Dô, Pierre Demontrond, Hubert Curcio, Simon Deshayes, Jeannick Madelaine, Dimitri Leite Ferreira, Leonard Jacson, Kilian Lecrosnier, François Chevalier, Florian Guisier, Edouard Dantoing, Alexandra Leconte, François Christy, Mathieu Césaire, Mathieu Césaire

Obter o texto integral